The Freundlich group is located at Rutgers University in the Department of Pharmacology, Physiology and Neuroscience and the Department of Medicine (Division of Infectious Diseases, Center for Emerging & Re-emerging Pathogens). Professor Freundlich is a member of the Infection, Immunity & Inflammation, Biomedical Engineering, and Molecular Biology, Genetics & Cancer tracks, while also holding a full member appointment in the graduate program for the Department of Medicinal Chemistry. The Freundlich laboratory is positioned at the intersection of computation, chemistry, and biology to develop new tools that contribute to our understanding of the pathogenesis of infectious diseases (caused by M. tuberculosis, ESKAPE bacteria, and select viruses) and translate these toward the discovery of novel therapeutic strategies. The group is indebted to funding primarily from the National Institutes of Health.